NEW YORK (GenomeWeb News) – Sigma-Aldrich said Tuesday that it will distribute Stemgent’s lentiviral vector-based technologies to the stem cell research community through a global agreement.

The worldwide distribution agreement covers Stemgent’s lentivirus-based delivery systems for induced pluripotent stem cells.

It includes Stemgent’s viral vectors, Sigma-Aldrich’s lentivirus technology, and Dox Inducible expression from Heidelberg, Germany-based TET Systems.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.